Activation of peroxisome proliferator-activated receptor-γ induces apoptosis on acute promyelocytic leukemia cells via downregulation of XIAP

International Journal of Molecular Medicine

Volumn 24, Issue 5, 2009, Pages 623-632

  Liu, Jia Jun ^a   Guo, Yun Wei ^a   Fang, Zhi Gang ^a   Si, Xiao Ning ^a   Wu, Xiang Yuan ^a   Liu, Pei Qing ^b   Lin, Dong Jun ^a   Xiao, Ruo Zhi ^a   Xu, Yan ^a   Wang, Chun Zhi ^a   Li, Xu Dong ^a   He, Yi ^a   Huang, Ren Wei ^c  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c NONE

Author keywords

Acute promyelocytic leukemia; Apoptosis; Peroxisome proliferator activated receptor ; X linked inhibitor of apoptosis protein

Indexed keywords

1396 12; 2 CHLORO 5 NITROBENZANILIDE; ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 7; CASPASE 9; CIGLITAZONE; ENZYME PRECURSOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL DESTRUCTION; CANCER INHIBITION; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DETERMINATION; DNA FRAGMENTATION; DOSE TIME EFFECT RELATION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; MEMBRANE DAMAGE; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STAINING; WESTERN BLOTTING;

ANILIDES; ANILINE COMPOUNDS; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SHAPE; DNA FRAGMENTATION; DOWN-REGULATION; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICROTUBULE-ASSOCIATED PROTEINS; PHENYLUREA COMPOUNDS; PPAR GAMMA; PROTEASE INHIBITORS; STAINING AND LABELING; THIAZOLIDINEDIONES; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 70350786138     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000273     Document Type: Article

References (33)

1. Zoete V, Grosdidier A and Michielin O: Peroxisome proliferator-activated receptor structures: ligand specificity, molecular switch and interactions with regulators. Biochim Biophys Acta 1771: 915-925, 2007.
2. Krishnan A, Nair SA and Pillai MR: Biology of PPAR gamma in cancer: a critical review on existing lacunae. Curr Mol Med 7: 532-540, 2007.
3. Giaginis C, Margeli A and Theocharis S: Peroxisome proliferator-activated receptor-gamma ligands as investigational modulators of angiogenesis. Expert Opin Investig Drugs 16: 1561-1572, 2007.
4. Ondrey F: Peroxisome proliferator-activated receptor gamma pathway targeting in carcinogenesis: implications for chemoprevention. Clin Cancer Res 15: 2-8, 2009.
5. Saiki M, Hatta Y, Yamazaki T, Itoh T, Enomoto Y, Takeuchi J, Sawada U, Aizawa S and Horie T: Pioglitazone inhibits the growth of human leukemia cell lines and primary leukemia cells while sparing normal hematopoietic stem cells. Int J Oncol 29: 437-443, 2006.
6. Wang T, Xu J, Yu X, Yang R and Han ZC: Peroxisome proliferator-activated receptor γ in malignant disease. Crit Rev Oncol Hematol 58: 1-14, 2006.
7. Ulivieri C and Baldari CT: The potential of peroxisome proliferator-activated receptor gamma (PPAR gamma) ligands in the treatment of hematological malignancies. Mini Rev Med Chem 7: 877-887, 2007.
8. Coyle AT, O'Keeffe MB and Kinsella BT: 15-deoxy Delta12,14-prostaglandin J2 suppresses transcription by promoter 3 of the human thromboxane A2 receptor gene through peroxisome proliferator-activated receptor gamma in human erythroleukemia cells. FEBS J 272: 4754-4773, 2005.
9. Richard CL and Blay J: Thiazolidinedione drugs down-regulate CXCR4 expression on human colorectal cancer cells in a peroxisome proliferator activated receptor γ-dependent manner. Int J Oncol 30: 1215-1222, 2007.
10. Cekanova M, Yuan JS, Li X, Kim K and Baek SJ: Gene alterations by peroxisome proliferator-activated receptor γ agonists in human colorectal cancer cells. Int J Oncol 32: 809-819, 2008.
11. Mrówka P, Glodkowska E, Nowis D, Legat M, Issat T, Makowski M, Szokalska A, Janowska S, Stoklosa T, Jakóbisiak M and Golab J: Ciglitazone, an agonist of peroxisome proliferator-activated receptor γ, exerts potentiated cytostatic/cytotoxic effects against tumor cells when combined with lovastatin. Int J Oncol 32: 249-255, 2008.
12. Schimmer AD: Induction of apoptosis in lymphoid and myeloid leukemia. Curr Oncol Rep 8: 430-436, 2006.
13. Barbera M, Kettunen MI, Caputo A, Hu DE, Gobbi S, Brindle KM and Carrara M: Immune-modulating and anti-vascular activities of two xanthenone acetic acid analogues: A comparative study to DMXAA. Int J Oncol 34: 273-279, 2009.
14. Xiao Y, Bi C, Fan Y, Cui C, Zhang X and Dou QP: L-glutamine Schiff base copper complex as a proteasome inhibitor and an apoptosis inducer in human cancer cells. Int J Oncol 33: 1073-1079, 2008.
15. Liu HB, Voso MT, Gumiero D, Duong J, McKendrick JJ and Dear AE: The anti-leukemic effect of a novel histone deacetylase inhibitor MCT-1 and 5-aza-cytidine involves augmentation of Nur77 and inhibition of MMP-9 expression. Int J Oncol 34: 573-579, 2009.
16. Song JH, Kim SH, Kim HJ, Hwang SY and Kim TS: Alleviation of the drug-resistant phenotype in idarubicin and cytosine arabinoside double-resistant acute myeloid leukemia cells by indomethacin. Int J Oncol 32: 931-936, 2008.
17. Conrad DM, Robichaud MR, Mader JS, Boudreau RT, Richardson AM, Giacomantonio CA and Hoskin DW: 2-Chloro-2′-deoxyadenosine-induced apoptosis in T leukemia cells is mediated via a caspase-3-dependent mitochondrial feedback amplification loop. Int J Oncol 32: 1325-1333, 2008.
18. Jabbour EJ, Estey E and Kantarjian HM: Adult acute myeloid leukemia. Mayo Clin Proc 81: 247-260, 2006.
19. Thomas X: Chemotherapy of acute leukemia in adults. Expert Opin Pharmacother 10: 221-223, 2009.
20. Lengfelder E, Saussele S, Weisser A, Buchner T and Hehlmann R: Treatment concepts of acute promyelocytic leukemia. Crit Rev Oncol Hematol 56: 261-274, 2005.
21. Zangemeister-Wittke U and Simon HU: An IAP in action: the multiple roles of survivin in differentiation, immunity and malignancy. Cell Cycle 3: 1121-1123, 2004.
22. Wrzesien-Kus A, Smolewski P, Sobczak-Pluta A, Wierzbowska A and Robak T: The inhibitor of apoptosis protein family and its antagonists in acute leukemias. Apoptosis 9: 705-715, 2004.
23. Testa U and Riccioni R: Deregulation of apoptosis in acute myeloid leukemia. Haematologica 92: 81-94, 2007.
24. Del Poeta G, Bruno A, Del Principe MI, Venditti A, Maurillo L, Buccisano F, Stasi R, Neri B, Luciano F, Siniscalchi A, de Fabritiis P and Amadori S: Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia. Curr Cancer Drug Targets 8: 207-222, 2008.
25. Tian S, Mewani RR, Kumar D, Li B, Danner MT, Ahmad I, Rahman A, Notario V, Dritschilo A, Kasid UN and Gokhale PC: Interaction and stabilization of X-linked inhibitor of apoptosis by Raf-1 protein kinase. Int J Oncol 29: 861-867, 2006.
26. Andjilani M, Droz JP, Benahmed M and Tabone E: Downregulation of FAK and IAPs by laminin during cisplatin-induced apoptosis in testicular germ cell tumors. Int J Oncol 28: 535-542, 2006.
27. Schimmer AD: Apoptosis in leukemia: from molecular pathways to targeted therapies. Best Pract Res Clin Haematol 21: 5-11, 2008.
28. Tamm I, Richter S, Oltersdiorf D, Creutzig U, Harbott J, Scholz F, Karawajew L, Ludwig WD and Wuchter C: High expression levels of X-linked inhibitor of apoptosis protein and surviving correlate with poor overall survival in childhood de novo acute myeloid leukaemia. Clin Cancer Res 10: 3737-3744, 2004.
29. Schimmer AD, Dalili S, Batey RA and Riedl SJ: Targeting XIAP for the treatment of malignancy. Cell Death Differ 13: 179-188, 2006.
30. Cillessen SA, Reed JC, Welsh K, Pinilla C, Houghten R, Hooijberg E, Deurhof J, Castricum KC, Kortman P, Hess CJ, Ossenkoppele GJ, Meijer CJ and Oudejans JJ: Small-molecule XIAP antagonist restores caspase-9 mediated apoptosis in XIAP-positive diffuse large B-cell lymphoma cells. Blood 111: 369-375, 2008.
31. Gahr S, Ocker M, Ganslmayer M, Zopf S, Okamoto K, Hartl A, Leitner S, Hahn EG and Herold C: The combination of the histone-deacetylase inhibitor trichostatin A and gemcitabine induces inhibition of proliferation and increased apoptosis in pancreatic carcinoma cells. Int J Oncol 31: 567-576, 2007.
32. Philchenkov AA: Caspases as regulators of apoptosis and other cell functions. Biochemistry 68: 365-376, 2003.
33. Yasugi E, Horiuchi A, Uemura I, Okuma E, Nakatsu M, Saeki K, Kamisaka Y, Kagechika H, Yasuda K and Yuo A: Peroxisome proliferator-activated receptor γ ligands stimulate myeloid differentiation and lipogenensis in human leukemia NB4 cells. Dev Growth Differ 48: 177-188, 2006.